Cargando…
Cellular uptake and antiproliferative effects of 11-oxo-eicosatetraenoic acid
Cyclooxygenases (COX) metabolize arachidonic acid (AA) to hydroxyeicosatetraenoic acids (HETE), which can then be oxidized by dehydrogenases, such as 15-hydroxyprostaglandin dehydrogenase (15-PGDH), to oxo-eicosatetraenoic acids (ETE). We have previously established that 11-oxo-eicosatetraenoic acid...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Biochemistry and Molecular Biology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793611/ https://www.ncbi.nlm.nih.gov/pubmed/23945567 http://dx.doi.org/10.1194/jlr.M040741 |
_version_ | 1782287084236570624 |
---|---|
author | Snyder, Nathaniel W. Revello, Sonia D. Liu, Xiaojing Zhang, Suhong Blair, Ian A. |
author_facet | Snyder, Nathaniel W. Revello, Sonia D. Liu, Xiaojing Zhang, Suhong Blair, Ian A. |
author_sort | Snyder, Nathaniel W. |
collection | PubMed |
description | Cyclooxygenases (COX) metabolize arachidonic acid (AA) to hydroxyeicosatetraenoic acids (HETE), which can then be oxidized by dehydrogenases, such as 15-hydroxyprostaglandin dehydrogenase (15-PGDH), to oxo-eicosatetraenoic acids (ETE). We have previously established that 11-oxo-eicosatetraenoic acid (oxo-ETE) and 15-oxo-ETE are COX-2/15-PGDH-derived metabolites. Stable isotope dilution (SID) chiral liquid chromatography coupled with electron capture atmospheric pressure chemical ionization (ECAPCI) single reaction monitoring (SRM) MS has been used to quantify uptake of 11-oxo-ETE and 15-oxo-ETE in both LoVo cells and human umbilical vein endothelial cells (HUVEC). Intracellular 11-oxo- and 15-oxo-ETE concentrations reached maximum levels within 1 h and declined rapidly, with significant quantitative differences in uptake between the LoVo cells and the HUVECs. Maximal intracellular concentrations of 11-oxo-ETE were 0.02 ng/4 × 10(5) cells in the LoVo cells and 0.58 ng/4 × 10(5) cells in the HUVECs. Conversely, maximal levels of 15-oxo-ETE were 0.21 ng/4 × 10(5) in the LoVo cells and 0.01 ng/4 × 10(5) in the HUVECs. The methyl esters of both 11-oxo- and 15-oxo-ETE increased the intracellular concentrations of the corresponding free oxo-ETEs by 3- to 8-fold. 11-oxo-ETE, 15-oxo-ETE, and their methyl esters inhibited proliferation in both HUVECs and LoVo cells at concentrations of 2–10 μM, with 11-oxo-ETE methyl ester being the most potent inhibitor. Cotreatment with probenecid, an inhibitor of multiple drug resistance transporters (MRP)1 and 4, increased the antiproliferative effect of 11-oxo-ETE methyl ester in LoVo cells and increased the intracellular concentration of 11-oxo-ETE from 0.05 ng/4 × 10(5) cells to 0.18 ng/4 × 10(5) cells. Therefore, this study has established that the COX-2/15-PGDH-derived eicosanoids 11-oxo- and 15-oxo-ETE enter target cells, that they inhibit cellular proliferation, and that their inhibitory effects are modulated by MRP exporters. |
format | Online Article Text |
id | pubmed-3793611 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | The American Society for Biochemistry and Molecular Biology |
record_format | MEDLINE/PubMed |
spelling | pubmed-37936112013-11-01 Cellular uptake and antiproliferative effects of 11-oxo-eicosatetraenoic acid Snyder, Nathaniel W. Revello, Sonia D. Liu, Xiaojing Zhang, Suhong Blair, Ian A. J Lipid Res Research Articles Cyclooxygenases (COX) metabolize arachidonic acid (AA) to hydroxyeicosatetraenoic acids (HETE), which can then be oxidized by dehydrogenases, such as 15-hydroxyprostaglandin dehydrogenase (15-PGDH), to oxo-eicosatetraenoic acids (ETE). We have previously established that 11-oxo-eicosatetraenoic acid (oxo-ETE) and 15-oxo-ETE are COX-2/15-PGDH-derived metabolites. Stable isotope dilution (SID) chiral liquid chromatography coupled with electron capture atmospheric pressure chemical ionization (ECAPCI) single reaction monitoring (SRM) MS has been used to quantify uptake of 11-oxo-ETE and 15-oxo-ETE in both LoVo cells and human umbilical vein endothelial cells (HUVEC). Intracellular 11-oxo- and 15-oxo-ETE concentrations reached maximum levels within 1 h and declined rapidly, with significant quantitative differences in uptake between the LoVo cells and the HUVECs. Maximal intracellular concentrations of 11-oxo-ETE were 0.02 ng/4 × 10(5) cells in the LoVo cells and 0.58 ng/4 × 10(5) cells in the HUVECs. Conversely, maximal levels of 15-oxo-ETE were 0.21 ng/4 × 10(5) in the LoVo cells and 0.01 ng/4 × 10(5) in the HUVECs. The methyl esters of both 11-oxo- and 15-oxo-ETE increased the intracellular concentrations of the corresponding free oxo-ETEs by 3- to 8-fold. 11-oxo-ETE, 15-oxo-ETE, and their methyl esters inhibited proliferation in both HUVECs and LoVo cells at concentrations of 2–10 μM, with 11-oxo-ETE methyl ester being the most potent inhibitor. Cotreatment with probenecid, an inhibitor of multiple drug resistance transporters (MRP)1 and 4, increased the antiproliferative effect of 11-oxo-ETE methyl ester in LoVo cells and increased the intracellular concentration of 11-oxo-ETE from 0.05 ng/4 × 10(5) cells to 0.18 ng/4 × 10(5) cells. Therefore, this study has established that the COX-2/15-PGDH-derived eicosanoids 11-oxo- and 15-oxo-ETE enter target cells, that they inhibit cellular proliferation, and that their inhibitory effects are modulated by MRP exporters. The American Society for Biochemistry and Molecular Biology 2013-11 /pmc/articles/PMC3793611/ /pubmed/23945567 http://dx.doi.org/10.1194/jlr.M040741 Text en Copyright © 2013 by the American Society for Biochemistry and Molecular Biology, Inc. http://creativecommons.org/licenses/by/3.0/ Author's Choice—Final version full access. Creative Commons Attribution Unported License (http://creativecommons.org/licenses/by/3.0/) applies to Author Choice Articles |
spellingShingle | Research Articles Snyder, Nathaniel W. Revello, Sonia D. Liu, Xiaojing Zhang, Suhong Blair, Ian A. Cellular uptake and antiproliferative effects of 11-oxo-eicosatetraenoic acid |
title | Cellular uptake and antiproliferative effects of 11-oxo-eicosatetraenoic acid |
title_full | Cellular uptake and antiproliferative effects of 11-oxo-eicosatetraenoic acid |
title_fullStr | Cellular uptake and antiproliferative effects of 11-oxo-eicosatetraenoic acid |
title_full_unstemmed | Cellular uptake and antiproliferative effects of 11-oxo-eicosatetraenoic acid |
title_short | Cellular uptake and antiproliferative effects of 11-oxo-eicosatetraenoic acid |
title_sort | cellular uptake and antiproliferative effects of 11-oxo-eicosatetraenoic acid |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793611/ https://www.ncbi.nlm.nih.gov/pubmed/23945567 http://dx.doi.org/10.1194/jlr.M040741 |
work_keys_str_mv | AT snydernathanielw cellularuptakeandantiproliferativeeffectsof11oxoeicosatetraenoicacid AT revellosoniad cellularuptakeandantiproliferativeeffectsof11oxoeicosatetraenoicacid AT liuxiaojing cellularuptakeandantiproliferativeeffectsof11oxoeicosatetraenoicacid AT zhangsuhong cellularuptakeandantiproliferativeeffectsof11oxoeicosatetraenoicacid AT blairiana cellularuptakeandantiproliferativeeffectsof11oxoeicosatetraenoicacid |